Australia Ophthalmic Devices Market Trends

Statistics for the 2023 & 2024 Australia Ophthalmic Devices market trends, created by Mordor Intelligence™ Industry Reports. Australia Ophthalmic Devices trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Market Trends of Australia Ophthalmic Devices Industry

This section covers the major market trends shaping the Australia Ophthalmic Devices Market according to our research experts:

Vision Correction Devices are Expected to Register a High Growth CAGR Over the Forecast Period

Vision correction devices or corrective lenses are used to aid and improve vision for those with common refractive errors like myopia, hypermetropia, astigmatism, and presbyopia. These visual impairments result in low vision. Moreover, these conditions seem to be rising in Australia, which helps increase the ophthalmic devices market.

Another aspect of the market's expansion is the rising prevalence of diabetes in the nation. According to the International Diabetes Federation, there were approximately 1,491.8 (in thousands) adult cases of diabetes in Australia in 2021, and that number is predicted to rise to 1,935.2 (in thousands) in 2045. In the upcoming years, the need for vision correction equipment for diagnostic procedures would be anticipated to increase due to the growing patient population. For instance, in November 2022, the Australia and New Zealand Child Myopia Working Group released a new report which stated that the COVID-19 pandemic appears to have had a dramatic impact on the progression of myopia. Myopia prevalence rose significantly in young schoolchildren during the COVID-19 pandemic with prevalence increasing by almost 400% in six-year-olds. This substantial myopic shift has not been seen in any other year to year comparison, making the cause possible due to the unusual occurrence of home confinement in 2020. As myopia becomes more comm, there will be a greater demand for vision correction technology.

Product launches are another factor in market growth. For instance, in September 2020, the Queensland University of Technology based in Australia stated that it is developing a new therapeutic contact lens that acts as a bandage for ocular surface injuries. Similarly, in August 2020, Bausch + Lomb received approval from Australia's Therapeutic Goods Administration (TGA) for the supply of BAUSCH + LOMB ULTRA ONE DAY daily disposable silicone hydrogel (SiHydaily) contact lenses.

Thus, due to the abovementioned factors, the market is expected to grow in the future.

Australia Ophthalmic Devices Market  :  Incidence of New Diabetes Cases (in Thousands), Australia, 2021-2045

Intraocular Lenses Segment is Expected to Have Significant Share Over the Forecast Period

An intraocular lens (IOL) is a lens that is implanted in the eye, usually replacing the existing crystalline lens. The increasing prevalence of cataracts is one of the key factors in segmental growth. For instance, in October 2022, a research article published by the Sax Institute stated that cataract is a leading cause of visual impairment in Australia, affecting 20% of Aboriginal and Torres Strait Islander (Indigenous) people (40 years and older) and 14% of non-Indigenous Australians (50 years and older).1 People with cataracts experience blurred vision, reduced contrast sensitivity, and increased glare sensitivity, affecting their ability to work, care for others, drive, and perform activities of daily living. Vision loss from cataracts disproportionately affects Indigenous Australians (adjusted odds ratio: 2.95) and people with lower educational attainment and socioeconomic status. In addition, the Royal Australian and New Zealand College of Ophthalmologists in January 2022 stated that glaucoma is characterized by an increase in intraocular pressure that necessitates long-term treatment. Glaucoma is estimated to affect 2.2% of Australians over the age of 50. By 2025, Australia's glaucoma prevalence is expected to rise to 379,000 patients. Thus, the increasing prevalence of cataracts and glaucoma is expected to increase the adoption of intraocular lenses which is expected to increase segmental growth.

The expansion of new market players in the country is another factor in market growth. For instance, in September 2020, Alcon launched AcrySof IQ Vivity IOL in Australia. Vivity is a non-diffractive extended depth of focus IOL with Alcon's proprietary non-diffractive X-WAVE technology, which stretches and shifts light without splitting it. Thus, the increasing prevalence of vision impairment coupled with expansions by key market players is expected to increase segmental growth over the forecast period.

Australia Ophthalmic Devices Market :  Estimated Cases of Glaucoma (in Percentage), By Community Type, Australia, 2021

Australia Ophthalmic Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)